Reassessment of HLA-G isoform specificity of MEM-G/9 and 4H84 monoclonal antibodies

Tissue Antigens

Volumn 80, Issue 3, 2012, Pages 231-238

  Zhao, L ^a   Teklemariam, T ^a   Hantash, B M ^a  

^a Escape Therapeutics Inc   (United States)

Author keywords

Characterization; Human leukocyte antigen G; Monoclonal antibodies

Indexed keywords

EPITOPE; HLA G ANTIGEN; ISOPROTEIN; MONOCLONAL ANTIBODY; MONOCLONAL ANTIBODY 4H84; MONOCLONAL ANTIBODY MEM 9; MONOCLONAL ANTIBODY MEM G; UNCLASSIFIED DRUG;

ANIMAL CELL; ANTIBODY SPECIFICITY; ANTIGEN RECOGNITION; ARTICLE; CELL STRAIN K 562; CLINICAL ASSESSMENT; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; HUMAN CELL; IMMUNOFLUORESCENCE; LEUKEMIA CELL LINE; MESENCHYMAL STEM CELL; MOUSE; NONHUMAN; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN UNFOLDING; SKIN FIBROBLAST; WESTERN BLOTTING;

AMINO ACID SEQUENCE; ANTIBODIES, MONOCLONAL; ANTIBODY SPECIFICITY; BETA 2-MICROGLOBULIN; CELL LINE, TUMOR; FLOW CYTOMETRY; FLUORESCENT ANTIBODY TECHNIQUE; HLA-G ANTIGENS; HUMANS; MOLECULAR SEQUENCE DATA; PROTEIN BINDING; PROTEIN ISOFORMS; TRANSDUCTION, GENETIC;

EID: 84864803728     PISSN: 00012815     EISSN: 13990039     Source Type: Journal    
DOI: 10.1111/j.1399-0039.2012.01922.x     Document Type: Article

References (28)

1. Apps R, Gardner L, Moffett A. A critical look at HLA-G. Trends Immunol 2008: 29: 313-21.
2. Kirszenbaum M, Moreau P, Gluckman E, Dausset J, Carosella E. An alternatively spliced form of HLA-G mRNA in human trophoblasts and evidence for the presence of HLA-G transcript in adult lymphocytes. Proc Natl Acad Sci U S A 1994: 91: 4209-13.
3. Ishitani A, Geraghty DE. Alternative splicing of HLA-G transcripts yields proteins with primary structures resembling both class I and class II antigens. Proc Natl Acad Sci U S A 1992: 89: 3947-51.
4. Carosella ED, Dausset J, Kirszenbaum M. HLA-G revisited. Immunol Today 1996: 17: 407-9.
5. Rouas-Freiss N, Marchal RE, Kirszenbaum M, Dausset J, Carosella ED. The alpha1 domain of HLA-G1 and HLA-G2 inhibits cytotoxicity induced by natural killer cells: is HLA-G the public ligand for natural killer cell inhibitory receptors? Proc Natl Acad Sci U S A 1997: 94: 5249-54.
6. Rouas-Freiss N, Goncalves RM, Menier C, Dausset J, Carosella ED. Direct evidence to support the role of HLA-G in protecting the fetus from maternal uterine natural killer cytolysis. Proc Natl Acad Sci U S A 1997: 94: 11520-5.
7. Riteau B, Rouas-Freiss N, Menier C, Paul P, Dausset J, Carosella ED. HLA-G2, -G3, and -G4 isoforms expressed as nonmature cell surface glycoproteins inhibit NK and antigen-specific CTL cytolysis. J Immunol 2001: 166: 5018-26.
8. Bahri R, Hirsch F, Josse A et al. Soluble HLA-G inhibits cell cycle progression in human alloreactive T lymphocytes. J Immunol 2006: 176: 1331-9.
9. LeMaoult J, Caumartin J, Daouya M et al. Immune regulation by pretenders: cell-to-cell transfers of HLA-G make effector T cells act as regulatory cells. Blood 2007: 109: 2040-8.
10. Caumartin J, Favier B, Daouya M et al. Trogocytosis-based generation of suppressive NK cells. EMBO J 2007: 26: 1423-33.
11. Horuzsko A, Lenfant F, Munn DH, Mellor AL. Maturation of antigen-presenting cells is compromised in HLA-G transgenic mice. Int Immunol 2001: 13: 385-94.
12. Riteau B, Menier C, Khalil-Daher I et al. HLA-G inhibits the allogeneic proliferative response. J Reprod Immunol 1999: 43: 203-11.
13. Kovats S, Main EK, Librach C, Stubblebine M, Fisher SJ, DeMars R. A class I antigen, HLA-G, expressed in human trophoblasts. Science 1990: 248: 220-3.
14. Shih Ie M. Application of human leukocyte antigen-G expression in the diagnosis of human cancer. Hum Immunol 2007: 68: 272-6.
15. Singer G, Rebmann V, Chen YC et al. HLA-G is a potential tumor marker in malignant ascites. Clin Cancer Res 2003: 9: 4460-4.
16. Bukur J, Rebmann V, Grosse-Wilde H et al. Functional role of human leukocyte antigen-G up-regulation in renal cell carcinoma. Cancer Res 2003: 63: 4107-11.
17. Singer G, Kurman RJ, McMaster MT, Shih Ie M. HLA-G immunoreactivity is specific for intermediate trophoblast in gestational trophoblastic disease and can serve as a useful marker in differential diagnosis. Am J Surg Pathol 2002: 26: 914-20.
18. Nuckel H, Rebmann V, Durig J, Duhrsen U, Grosse-Wilde H. HLA-G expression is associated with an unfavorable outcome and immunodeficiency in chronic lymphocytic leukemia. Blood 2005: 105: 1694-8.
19. Fournel S, Huc X, Aguerre-Girr M et al. Comparative reactivity of different HLA-G monoclonal antibodies to soluble HLA-G molecules. Tissue Antigens 2000: 55: 510-8.
20. Menier C, Saez B, Horejsi V et al. Characterization of monoclonal antibodies recognizing HLA-G or HLA-E: new tools to analyze the expression of nonclassical HLA class I molecules. Hum Immunol 2003: 64: 315-26.
21. McMaster M, Zhou Y, Shorter S et al. HLA-G isoforms produced by placental cytotrophoblasts and found in amniotic fluid are due to unusual glycosylation. J Immunol 1998: 160: 5922-8.
22. Polakova K, Kuba D, Russ G. The 4H84 monoclonal antibody detecting beta2m free nonclassical HLA-G molecules also binds to free heavy chains of classical HLA class I antigens present on activated lymphocytes. Hum Immunol 2004: 65: 157-62.
23. Le Bouteiller P, Barakonyi A, Giustiniani J et al. Engagement of CD160 receptor by HLA-C is a triggering mechanism used by circulating natural killer (NK) cells to mediate cytotoxicity. Proc Natl Acad Sci U S A 2002: 99: 16963-8.
24. Apps R, Murphy SP, Fernando R, Gardner L, Ahad T, Moffett A. Human leucocyte antigen (HLA) expression of primary trophoblast cells and placental cell lines, determined using single antigen beads to characterize allotype specificities of anti-HLA antibodies. Immunology 2009: 127: 26-39.
25. Dicker A, Le Blanc K, Astrom G et al. Functional studies of mesenchymal stem cells derived from adult human adipose tissue. Exp Cell Res 2005: 308: 283-90.
26. Polakova K, Bennink JR, Yewdell JW, Bystricka M, Bandzuchova E, Russ G. Mild acid treatment induces cross-reactivity of 4H84 monoclonal antibody specific to nonclassical HLA-G antigen with classical HLA class I molecules. Hum Immunol 2003: 64: 256-64.
27. + cells by interacting with CD8. J Immunol 2000: 164: 6100-4.
28. Morales PJ, Pace JL, Platt JS, Langat DK, Hunt JS. Synthesis of beta(2)-microglobulin-free, disulphide-linked HLA-G5 homodimers in human placental villous cytotrophoblast cells. Immunology 2007: 122: 179-88.